No Data
No Data
Revance Therapeutics Reports Q1 2024 Financial Results: Revenue Growth Amidst Rising Operating ...
Revance Therapeutics Down Over 21%, on Pace for Largest Percent Decrease Since October 2021 -- Data Talk
Revance Therapeutics, Inc. (RVNC) is currently at $3.37, down $0.92 or 21.42% --Would be lowest close since April 25, 2024, when it closed at $3.29 --On pace for largest percent decrease since Oct.
NVAX, GRPN and MVIS Among Mid-day Movers
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents
12 Health Care Stocks Moving In Friday's Intraday Session
GainersNovavax (NASDAQ:NVAX) stock increased by 110.7% to $9.42 during Friday's regular session. The market value of their outstanding shares is at $1.3 billion. The company's, Q1 earnings came out to
Express News | Revance Therapeutics Shares Are Trading Lower Following Mixed Q1 Earnings